{"id":59426,"date":"2021-10-11T00:00:00","date_gmt":"2021-10-11T00:00:00","guid":{"rendered":"http:\/\/lebanonnewsgazette.com\/?guid=fd354ecaeafc4e6f04db40264e7d9a74"},"modified":"2021-10-11T00:00:00","modified_gmt":"2021-10-11T00:00:00","slug":"merck-seeks-fda-authorization-for-covid-treatment-pill","status":"publish","type":"post","link":"https:\/\/lebanonnewsgazette.com\/merck-seeks-fda-authorization-for-covid-treatment-pill\/","title":{"rendered":"MERCK SEEKS FDA AUTHORIZATION FOR COVID TREATMENT PILL"},"content":{"rendered":"
US pharmaceutical giant Merck said Monday that it has applied for emergency use authorization of its oral anti-Covid drug in the United States, a major step towards finding a simple pill to treat the disease.<\/p>\n<\/p>\n
Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalisations by 50 percent.<\/p>\n<\/p>\n
It said it was working “with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months.”<\/p>\n<\/p>\n
“The extraordinary impact of this pandemic demands that we move with unprecedented urgency,” Robert Davis, chief executive officer and president of Merck, said in the statement.<\/p>\n<\/p>\n
“That is what our teams have done by submitting this application for molnupiravir to the FDA within 10 days of receiving the data,” he added.<\/p>\n<\/p>\n
Wendy Holman, chief executive of Merck’s partner Ridgeback Biotherapeutics, called the application a “critical step towards making molnupiravir available to people who may benefit from an oral antiviral medicine that can be taken at home shortly after diagnosis with Covid-19.”<\/p>\n<\/p>\n
Source: National News Agency<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"
US pharmaceutical giant Merck said Monday that it has applied for emergency use authorization of its oral anti-Covid drug in the United States, a major step towards finding a simple pill to treat the disease.Merck has submitted the application for moln…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"yoast_head":"\n